PMID- 33115676 OWN - NLM STAT- MEDLINE DCOM- 20210621 LR - 20210621 IS - 1879-0720 (Electronic) IS - 0928-0987 (Linking) VI - 158 DP - 2021 Mar 1 TI - Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets. PG - 105619 LID - S0928-0987(20)30407-3 [pii] LID - 10.1016/j.ejps.2020.105619 [doi] AB - Hot-melt extruded (HME) filaments are an essential intermediate product for the three- dimensional (3D) printing of drug delivery systems (DDSs) by the fused deposition modelling (FDM) process. The aim of this study was to design novel polymeric 3D-printable HME filaments loaded with active pharmaceutical ingredients (APIs). The physical solid-state properties, mechanical properties, drug release and short-term storage stability of the filaments and 3D-printed DDSs were studied. Physical powder mixtures of polycaprolactone (PCL), plasticizer and API were manually blended, extruded by a single-screw extruder, and printed by a table-top FDM 3D-printing system. The composition of PCL and arabic gum (ARA) enabled the incorporation of 20%, 30% and 40% (w/w) of indomethacin (IND) and theophylline (THEO) into the HME filaments. The uneven distribution of API throughout the filaments impaired 3D printing. The HME filaments loaded with 20% IND or THEO were selected for the further analysis and printing tests (the ratio of PCL, ARA and IND or THEO was 7:1:2, respectively). The IND filaments were yellowish, mechanically strong and flexible, and they had a uniform filament diameter and smooth outer surface. The filaments containing THEO were smooth and off-white. The 3D-printed tablets fabricated from IND or THEO-loaded filaments showed sustained drug release in vitro. The drug release rate, however, significantly increased by changing the geometry of 3D-printed tablets from a conventional tablet structure to an unorthodox lattice ("honeycomb") structure. Overall, the combination of PCL and ARA provides an interesting novel polymeric carrier system for 3D-printable HME filaments and tablets. CI - Copyright (c) 2020 Elsevier B.V. All rights reserved. FAU - Viidik, Laura AU - Viidik L AD - Institute of Pharmacy, Faculty of Medicine, University of Tartu, Estonia. Electronic address: laura.viidik@ut.ee. FAU - Vesala, Jemina AU - Vesala J AD - School of Pharmacy, PromisLab, University of Eastern Finland, Finland. FAU - Laitinen, Riikka AU - Laitinen R AD - School of Pharmacy, PromisLab, University of Eastern Finland, Finland. FAU - Korhonen, Ossi AU - Korhonen O AD - School of Pharmacy, PromisLab, University of Eastern Finland, Finland. FAU - Ketolainen, Jarkko AU - Ketolainen J AD - School of Pharmacy, PromisLab, University of Eastern Finland, Finland. FAU - Aruvali, Jaan AU - Aruvali J AD - Department of Geology, Institute of Ecology and Earth Sciences, Faculty of Science and Technology, University of Tartu, Estonia. FAU - Kirsimae, Kalle AU - Kirsimae K AD - Department of Geology, Institute of Ecology and Earth Sciences, Faculty of Science and Technology, University of Tartu, Estonia. FAU - Kogermann, Karin AU - Kogermann K AD - Institute of Pharmacy, Faculty of Medicine, University of Tartu, Estonia. FAU - Heinamaki, Jyrki AU - Heinamaki J AD - Institute of Pharmacy, Faculty of Medicine, University of Tartu, Estonia. FAU - Laidmae, Ivo AU - Laidmae I AD - Institute of Pharmacy, Faculty of Medicine, University of Tartu, Estonia; Department of Immunology, Institute of Biomedicine and Translational Medicine, Faculty of Medicine, University of Tartu, Estonia. FAU - Ervasti, Tuomas AU - Ervasti T AD - School of Pharmacy, PromisLab, University of Eastern Finland, Finland. LA - eng PT - Journal Article DEP - 20201025 PL - Netherlands TA - Eur J Pharm Sci JT - European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences JID - 9317982 RN - 0 (Polyesters) RN - 0 (Tablets) RN - 24980-41-4 (polycaprolactone) SB - IM MH - Drug Liberation MH - *Polyesters MH - *Printing, Three-Dimensional MH - Tablets MH - Technology, Pharmaceutical OTO - NOTNLM OT - 3D-printing OT - arabic gum OT - drug release OT - filament OT - fused deposition modelling OT - hot-melt extrusion OT - polycaprolactone EDAT- 2020/10/30 06:00 MHDA- 2021/06/22 06:00 CRDT- 2020/10/29 05:32 PHST- 2020/05/31 00:00 [received] PHST- 2020/10/04 00:00 [revised] PHST- 2020/10/19 00:00 [accepted] PHST- 2020/10/30 06:00 [pubmed] PHST- 2021/06/22 06:00 [medline] PHST- 2020/10/29 05:32 [entrez] AID - S0928-0987(20)30407-3 [pii] AID - 10.1016/j.ejps.2020.105619 [doi] PST - ppublish SO - Eur J Pharm Sci. 2021 Mar 1;158:105619. doi: 10.1016/j.ejps.2020.105619. Epub 2020 Oct 25.